Literature DB >> 18289668

HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization.

Shy Chyi Wuang1, Koon Gee Neoh, En-Tang Kang, Daniel W Pack, Deborah E Leckband.   

Abstract

Polypyrrole-Fe3O4 nanospheres were synthesized via an emulsion polymerization method with hyaluronic acid as the surfactant. Hyaluronic acid offers the advantages of biocompatibility, cell adhesive property and the availability of functional groups for attachment of other molecules. The nanospheres were further functionalized with herceptin, and the efficacy of uptake of the functionalized nanospheres by human breast cancer cells was evaluated. It is envisioned that the combination of hyaluronic acid with its cell adhesive property and herceptin would result in high efficacy of internalization of the nanospheres by the cancer cells via a HER-2-mediated endocytosis. Our results showed that this is indeed the case and that the high concentration of herceptin-functionalized magnetic nanospheres in the cancer cells offers great potential in cancer cell targeting and treatment. In addition, the magnetic property of these nanospheres was also critically investigated and the magnetization was found to be affected by the particles' environment. The combination of these cell-targeting magnetic carriers with chemotherapeutic agents will be highly advantageous for the preferential killing of cancer cells in hyperthermia treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18289668      PMCID: PMC2312094          DOI: 10.1016/j.biomaterials.2008.01.028

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  33 in total

Review 1.  Hyaluronan-cell interactions in cancer and vascular disease.

Authors:  Bryan P Toole; Thomas N Wight; Markku I Tammi
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

2.  Hyaluronan and tumor growth.

Authors:  Bryan P Toole; Vincent C Hascall
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

3.  In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines.

Authors:  J-L Merlin; M Barberi-Heyob; N Bachmann
Journal:  Ann Oncol       Date:  2002-11       Impact factor: 32.976

4.  Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.

Authors:  J C Sarup; R M Johnson; K L King; B M Fendly; M T Lipari; M A Napier; A Ullrich; H M Shepard
Journal:  Growth Regul       Date:  1991-06

5.  Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells.

Authors:  J R Bradley; D R Johnson; J S Pober
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

6.  Locoregional cancer treatment with magnetic drug targeting.

Authors:  C Alexiou; W Arnold; R J Klein; F G Parak; P Hulin; C Bergemann; W Erhardt; S Wagenpfeil; A S Lübbe
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

7.  MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles.

Authors:  Dmitri Artemov; Noriko Mori; Baasil Okollie; Zaver M Bhujwalla
Journal:  Magn Reson Med       Date:  2003-03       Impact factor: 4.668

8.  Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects.

Authors:  Bart S Hendriks; Lee K Opresko; H Steven Wiley; Douglas Lauffenburger
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

9.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

10.  Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation.

Authors:  G Brockhoff; B Heckel; E Schmidt-Bruecken; M Plander; F Hofstaedter; A Vollmann; S Diermeier
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

View more
  12 in total

1.  Acid-Sensitive Magnetic Nanoparticles as Potential Drug Depots.

Authors:  Shy Chyi Wuang; Koon Gee Neoh; En-Tang Kang; Deborah E Leckband; Daniel W Pack
Journal:  AIChE J       Date:  2011-06       Impact factor: 3.993

2.  Force dependent internalization of magnetic nanoparticles results in highly loaded endothelial cells for use as potential therapy delivery vectors.

Authors:  Cristin MacDonald; Kenneth Barbee; Boris Polyak
Journal:  Pharm Res       Date:  2012-01-11       Impact factor: 4.200

3.  Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions.

Authors:  J F Hainfeld; M J O'Connor; F A Dilmanian; D N Slatkin; D J Adams; H M Smilowitz
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

4.  Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applications.

Authors:  Eun-Kyung Lim; Bong Hyun Chung
Journal:  Nat Protoc       Date:  2016-01-07       Impact factor: 13.491

5.  Particle shape enhances specificity of antibody-displaying nanoparticles.

Authors:  Sutapa Barua; Jin-Wook Yoo; Poornima Kolhar; Aditya Wakankar; Yatin R Gokarn; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Quasi-cubic magnetite/silica core-shell nanoparticles as enhanced MRI contrast agents for cancer imaging.

Authors:  Jos L Campbell; Jyoti Arora; Simon F Cowell; Ashish Garg; Peter Eu; Suresh K Bhargava; Vipul Bansal
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

7.  Iron oxide-based nanomagnets in nanomedicine: fabrication and applications.

Authors:  Meng Meng Lin; Hyung-Hwan Kim; Hyuck Kim; Mamoun Muhammed; Do Kyung Kim
Journal:  Nano Rev       Date:  2010-02-22

8.  Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.

Authors:  Hongwei Chen; Liya Wang; Qiqi Yu; Weiping Qian; Diana Tiwari; Hong Yi; Andrew Y Wang; Jing Huang; Lily Yang; Hui Mao
Journal:  Int J Nanomedicine       Date:  2013-10-02

9.  Synthesis and application of magnetite dextran-spermine nanoparticles in breast cancer hyperthermia.

Authors:  Reza Avazzadeh; Ebrahim Vasheghani-Farahani; Masoud Soleimani; Saeid Amanpour; Mohsen Sadeghi
Journal:  Prog Biomater       Date:  2017-06-17

Review 10.  Current applications and future prospects of nanomaterials in tumor therapy.

Authors:  Yu Huang; Chao-Qiang Fan; Hui Dong; Su-Min Wang; Xiao-Chao Yang; Shi-Ming Yang
Journal:  Int J Nanomedicine       Date:  2017-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.